🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
AMP
$AMPH
🔒 US EquitiesAmphastar Pharmaceuticals, Inc.
AVG HISTORICAL GAP
-0.76%
MAX GAP RECORD
-22.68%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $AMPH
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$AMPH
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE) |
+13.48%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-22.68%
|
| Feb 26, 2026 Earnings Release 2026-02-26 (AFTER CLOSE) |
-15.29%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
+7.92%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
+3.10%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+0.65%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE) |
-3.14%
|
| Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE) |
-10.22%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.3%
Bullish Gaps (7)
Bearish Gaps (5)
Neutral / Flat (3)
📖 Intelligence Summary
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗